Johnson & Johnson JNJ
NYSE JNJ
$276.19 +3.87 (+1.42%)
As of: Nov 6, 2026 · 3:59 PM EST

Johnson & Johnson (JNJ) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Johnson & Johnson (JNJ) reported Depreciation & Amortization (CF) of $2.12 billion for Q3 2026, up 19.1% from $1.78 billion a year earlier and up 8.1% from the prior quarter.

Analysis

Johnson & Johnson (JNJ) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 27, 2026, Johnson & Johnson's Depreciation & Amortization (CF) came in at $8.09 billion, up 9.5% year-over-year; for FY2025, it was $7.5 billion, up 2.2% from FY2024.

  • Depreciation & Amortization (CF) has a four-year compound annual growth rate of 0.9% (FY2021 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $7.34 billion in FY2024 (-2.0%), $7.49 billion in FY2023 (+7.4%), $6.97 billion in FY2022 and $7.23 billion in FY2021.
  • The Q3 2026 figure ranks as the highest quarterly Depreciation & Amortization (CF) in data going back to Q4 2011.
  • Year over year, Depreciation & Amortization (CF) has now increased in each of the last four quarters, with growth averaging 5.6% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q4 2023 (growth of 29.5%); the low point was Q2 2024 (a decline of 7.9%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $1.96 billion (Q2 2026), $2 billion (Q1 2026) and $2.01 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 2.12 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 192.00 Mn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 1.61 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 1.58 Bn
10 Vertex Pharmaceuticals 138.73 Bn 110.72 Bn 2.91 Bn 69.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 27, 2026 2.12 Bn
Jun 28, 2026 1.96 Bn
Mar 29, 2026 2.00 Bn
Dec 28, 2025 2.01 Bn
Sep 28, 2025 1.78 Bn
Jun 29, 2025 1.94 Bn
Mar 30, 2025 1.77 Bn
Dec 29, 2024 1.90 Bn
Sep 29, 2024 1.85 Bn
Jun 30, 2024 1.78 Bn
Mar 31, 2024 1.82 Bn
Dec 31, 2023 1.84 Bn
Oct 1, 2023 1.83 Bn
Jul 2, 2023 1.93 Bn
Apr 2, 2023 1.88 Bn
Jan 1, 2023 1.42 Bn
Apr 3, 2022 1.77 Bn
Oct 3, 2021 1.81 Bn
Jul 4, 2021 1.84 Bn
Apr 4, 2021 1.89 Bn
API Access

Johnson & Johnson Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=JNJ&period=max&api_key=YOUR_API_KEY